- Home
- IOTR vs NXL Comparison
IOTR vs NXL Comparison
Compare IOTR & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- NXL
- Stock Information
- Founded
- IOTR 2019
- NXL 2010
- Country
- IOTR Singapore
- NXL United States
- Employees
- IOTR N/A
- NXL N/A
- Industry
- IOTR
- NXL Medical Specialities
- Sector
- IOTR
- NXL Health Care
- Exchange
- IOTR NYSE
- NXL Nasdaq
- Market Cap
- IOTR 29.5M
- NXL 24.2M
- IPO Year
- IOTR 2025
- NXL 2022
- Fundamental
- Price
- IOTR $0.47
- NXL $1.19
- Analyst Decision
- IOTR
- NXL Strong Buy
- Analyst Count
- IOTR 0
- NXL 1
- Target Price
- IOTR N/A
- NXL $5.00
- AVG Volume (30 Days)
- IOTR 651.9K
- NXL 126.6K
- Earning Date
- IOTR 01-01-0001
- NXL 05-13-2025
- Dividend Yield
- IOTR N/A
- NXL N/A
- EPS Growth
- IOTR N/A
- NXL N/A
- EPS
- IOTR N/A
- NXL N/A
- Revenue
- IOTR $9,578,336.00
- NXL $131,065.00
- Revenue This Year
- IOTR N/A
- NXL $79.59
- Revenue Next Year
- IOTR N/A
- NXL $334.65
- P/E Ratio
- IOTR N/A
- NXL N/A
- Revenue Growth
- IOTR 13.93
- NXL N/A
- 52 Week Low
- IOTR $0.31
- NXL $0.53
- 52 Week High
- IOTR $5.98
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- NXL 30.13
- Support Level
- IOTR N/A
- NXL $1.18
- Resistance Level
- IOTR N/A
- NXL $1.24
- Average True Range (ATR)
- IOTR 0.00
- NXL 0.07
- MACD
- IOTR 0.00
- NXL 0.02
- Stochastic Oscillator
- IOTR 0.00
- NXL 18.18
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.